Patent assignee · US · COMPANY

Altor Bioscience LLC

62Patents

53Active

62Granted

60Portfolio score

Filing activity: Oct 21, 1999 → Sep 25, 2024 · 3 expiring within 5 years

Most-cited patents

Patent	Title	Area	Cited by	Status
US8507222B2	Multimeric IL-15 soluble fusion molecules and methods of making and using same	Chemistry; Metallurgy	76	Active
US8163879B2	Fusion molecules and IL-15 variants	Chemistry; Metallurgy	62	Active
US8492118B2	Fusion molecules and IL-15 variants	Chemistry; Metallurgy	51	Active
US9428573B2	Multimeric IL-15 soluble fusion molecules and methods of making and using same	Chemistry; Metallurgy	45	Active
US9464127B2	Fusion molecules and IL-15 variants	Chemistry; Metallurgy	45	Active
US8940289B2	Fusion molecules and IL-15 variants	Chemistry; Metallurgy	44	Active
US9328159B2	Multimeric IL-15 soluble fusion molecules and methods of using same	Chemistry; Metallurgy	42	Active
US10150805B2	Multimeric IL-15 soluble fusion molecules and methods of making and using same	Chemistry; Metallurgy	41	Active
US9925247B2	IL-15-based molecules and methods of use thereof	Chemistry; Metallurgy	34	Active
US6534633B1	Polyspecific binding molecules and uses thereof	Chemistry; Metallurgy	31	Expired
US7456263B2	P53 binding T cell receptor molecules	Human Necessities	30	Expired
US10450359B2	IL-15 variants and uses thereof	Chemistry; Metallurgy	30	Active
US10358478B2	Multimeric IL-15 soluble fusion molecules and methods of making and using same	Chemistry; Metallurgy	25	Active
US9593152B2	Methods of treating disease with fusion molecules comprising IL-15 variants	Chemistry; Metallurgy	24	Active
US7141656B2	MHC complexes and uses thereof	Chemistry; Metallurgy	24	Expired
US7074904B2	MHC complexes and uses thereof	Emerging Cross-Sectional Technologies	24	Expired
US10537615B2	IL-15-based molecules and methods of use thereof	Chemistry; Metallurgy	23	Active
US8105830B2	Polyspecific binding molecules and uses thereof	Chemistry; Metallurgy	20	Expired
US10865230B2	Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains	Chemistry; Metallurgy	20	Active
US11046747B2	Multimeric IL-15 soluble fusion molecules and methods of making and using same	Chemistry; Metallurgy	19	Active
US10899821B2	Method of treating neoplasia with a multimeric IL-15 soluble fusion molecule	Chemistry; Metallurgy	16	Active
US11168138B2	Anti-PDL1, IL-15 and TGF-beta receptor combination molecules	Chemistry; Metallurgy	14	Active
US11173191B2	IL-15-based molecules and methods of use thereof	Chemistry; Metallurgy	12	Active
US11104716B2	Multimeric IL-15 soluble fusion molecules and methods of making and using same	Chemistry; Metallurgy	12	Active
US11471511B2	IL-15-based molecules and methods of use thereof	Chemistry; Metallurgy	11	Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.